LEADER 01450nam  2200361Ia 450 
001 9910698866303321
005 20090512152926.0
035   $a(CKB)5470000002397201
035   $a(OCoLC)320850746
035   $a(EXLCZ)995470000002397201
100   $a20090512d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ebiological product deviation reporting for licensed manufacturers of biological products other than blood and blood components
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research,$d[2006]
215   $ai, 18 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 12, 2009).
300   $a"October 2006".
320   $aIncludes bibliographical references (page 18).
517   $aGuidance for industry 
606   $aBiological products$xGovernment policy$zUnited States
615  0$aBiological products$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698866303321
996   $aGuidance for industry$93434577
997   $aUNINA